Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a
ClinicalTrials.gov study NCT01497002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.
ClinicalTrials.gov study NCT04931992. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
ClinicalTrials.gov study NCT05334693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
ClinicalTrials.gov study NCT01770158. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
ClinicalTrials.gov study NCT04708054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ClinicalTrials.gov study NCT05554393. IPD Sharing: YES. Countries: 3. Publications: 0.
Decitabine+Cladribine+Cytarabine+Granulocyte Colony-stimulating Factor (D-CLAG) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04373395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epacadostat, Idarubicin and Cytarabine (EIC) in AML
ClinicalTrials.gov study NCT03444649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
ClinicalTrials.gov study NCT04217278. IPD Sharing: NO. Countries: 1. Publications: 0.
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
ClinicalTrials.gov study NCT04050280. IPD Sharing: NO. Countries: 1. Publications: 0.
LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01198054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01758367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05577611. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT05942599. IPD Sharing: NO. Countries: 1. Publications: 0.
Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML
ClinicalTrials.gov study NCT03537560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
ClinicalTrials.gov study NCT06513273. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer(NK) Cell Therapy in r/r AML
ClinicalTrials.gov study NCT05665114. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
ClinicalTrials.gov study NCT05758610. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Venetoclax Combined with Intensive Chemotherapy in Different Subgroups of AML
ClinicalTrials.gov study NCT06635681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
ClinicalTrials.gov study NCT06394011. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.